Back to search
FDAFDA · Food and drugs·Recall number D-1446-2014

Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90

Published July 30, 2014 · Recall initiated: September 27, 2011

Summary

FDA records drug Class I recall D-1446-2014, published July 30, 2014 and initiated September 27, 2011. Recalling firm: Shamrock Medical Solutions Group LLC; Status: Terminated; Reported quantity: 89/120 mg tablets; Lot: Use By: 5/31/2013, Lot: 0021OC, NDC 62037-0696-90. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Shamrock Medical Solutions Group LLC
Distributor
Product was shipped to the following states: CO, MA, OH, TX & WY.
Lot
Use By: 5/31/2013, Lot: 0021OC, NDC 62037-0696-90
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90 recalled?

Yes. FDA published recall D-1446-2014 on July 30, 2014. Reported hazard: Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Telephone